152 related articles for article (PubMed ID: 31298347)
41. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
42. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
43. [In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine].
Zhang M; Yin XR; Luo YY; Lin X; Wang MC; He PC; Li J; Guo GL; Cai RH; Liu YL
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):593-7. PubMed ID: 16532967
[TBL] [Abstract][Full Text] [Related]
44. Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.
Hong B; Ren W; Song XT; Evel-Kabler K; Chen SY; Huang XF
Cancer Res; 2009 Oct; 69(20):8076-84. PubMed ID: 19789342
[TBL] [Abstract][Full Text] [Related]
45. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1.
Zhang M; Liu F; Jia H; Zhang Q; Yin L; Liu W; Li H; Yu B; Wu J
J Immunol; 2011 Aug; 187(4):1674-83. PubMed ID: 21742974
[TBL] [Abstract][Full Text] [Related]
47. [Antitumor effect of a triple negative breast cancer-dendritic cell fusion vaccine].
Zhang P; Liu R; Jiang H; Liu Y; Zhang Q; Huang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):778-83. PubMed ID: 22699053
[TBL] [Abstract][Full Text] [Related]
48. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J; Jacobs P; Doffek K; Sugg SL
J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
[TBL] [Abstract][Full Text] [Related]
49. B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer.
Lian T; Hao X; Li J; Wang H; Li C
Med Oncol; 2020 Nov; 37(11):107. PubMed ID: 33136217
[TBL] [Abstract][Full Text] [Related]
50. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells.
Koido S; Tanaka Y; Tajiri H; Gong J
Vaccine; 2007 Mar; 25(14):2610-9. PubMed ID: 17239504
[TBL] [Abstract][Full Text] [Related]
51. IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy.
Alters SE; Gadea JR; Holm B; Lebkowski J; Philip R
J Immunother; 1999 May; 22(3):229-36. PubMed ID: 10335482
[TBL] [Abstract][Full Text] [Related]
52. [In vitro cytokines-induced differentiation in mononuclear cell derived dendritic cells from chronic myeloid leukemia].
Zhang YF; Wu CY; Zhang LS; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):137-41. PubMed ID: 16584610
[TBL] [Abstract][Full Text] [Related]
53. [Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells].
Cai YG; Fang DC; Chen L; Wang DX; Luo YH; Tang XD; Chen T; Yang SM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3122-7. PubMed ID: 17313764
[TBL] [Abstract][Full Text] [Related]
54. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro].
Tang JF; Guan SH; Wang ZG
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216
[TBL] [Abstract][Full Text] [Related]
55. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
56. Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
Hwang EC; Jung SI; Lee HJ; Lee JJ; Kwon DD
Int Braz J Urol; 2017; 43(4):615-627. PubMed ID: 28266813
[TBL] [Abstract][Full Text] [Related]
57. Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood.
Guo G; Chen S; Zhang J; Luo L; Yu J; Dong H; Xu H; Su Z; Wu L
Vaccine; 2005 Nov; 23(45):5225-30. PubMed ID: 16171908
[TBL] [Abstract][Full Text] [Related]
58. Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.
Xu Y; Wang W; Gou A; Li H; Tian Y; Yao M; Yang R
Mol Med Rep; 2015 Jan; 11(1):583-8. PubMed ID: 25322862
[TBL] [Abstract][Full Text] [Related]
59. SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance.
Hu Q; Qin X; Qian G; Jiang S; Li H; Jiang M; Li X; Chen SY; Zang YQ
Mol Med Rep; 2008; 1(1):61-70. PubMed ID: 21479379
[TBL] [Abstract][Full Text] [Related]
60. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
